Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.

Conference Live infographic

Conference Live infographic

Conference Live gives you real-time insights, utilising the multimedia functionality of the smartphone in an innovative mobile app methodology. We conduct mobile conference research amongst physicians attending conferences, giving our clients real-time feedback and insight into delegates’ reactions as they happen. Our approach is very successful at engaging respondents, offers rich insights and immediate outputs.
 

read more »

HCV EU infographic

HCV EU infographic

Research findings from our Therapy HCV study shows that 28% of HCV patients in the EU are infected by sharing needles or drug equipment.

Our latest market snapshot offers an introduction to the real world patient data collected by our Therapy Watch HCV study, providing you with an overview of HCV patient profiles and treatment pathways.
Click here to view our infographic »
Sign up to receive Rapport Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here » 
 

read more »

Spondyloarthritis infographic

Spondyloarthritis infographic

Spondyloarthritis is the name for a family of arthritis causing inflammatory rheumatic diseases; including Axial spondyloarthritis, Psoriatic arthritis and Ankylosing spondylitis, which affects around 1-2% of the global population.

Click here to view our Spondyloarthritis infographic which provides you with an overview of spondyloarthritis patient profiles and treatment pathways.
Sign up to receive Rapport Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here » 
 

read more »

RA Perceptions infographic

RA Perceptions infographic

HCPs predict the future of the biologics market

Findings from a recent survey of physicians across Europe has revealed that, despite stiff competition from newer biologics, biosimilars and pipeline agents, physicians expect current market leaders Enbrel (etanercept) and Humira (adalimumab) to continue to lead the market and be used to treat over a third of Rheumatoid Arthritis (RA) patients in three years’ time. Nevertheless, the anti-TNF segment is predicted to experience a strong downturn with a 19% loss in share in the same period.
RA Perceptions is a market research study which is carried out every month amongst a panel of 200 physicians across five European countries (France, Germany, Italy, Spain and the UK) and asks physicians about current and future perceptions of the RA market. These findings are from the June survey. RA Perceptions is a component of a larger ongoing patient tracking study called Therapy Watch RA, conducted by global healthcare market research specialist Research Partnership. An infographic highlights the key findings from the study.

read more »

HCV LATAM infographic

HCV LATAM infographic

Hepatitis C virus (HCV) is well recognised as a worldwide problem with approximately 150 million chronic carriers. If left untreated HCV becomes a chronic health problem putting a huge strain on national healthcare resources. Within Latin America studies suggest that around 4.6 million people are currently infected with chronic HCV.
Click here to view our latest infographic, in which we provide an introduction to the HCV LATAM patient.
Find out more about our experience in emerging markets »
Sign up to receive Rapport Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here » 
 

read more »